Clinical trials: Escitalopram
Major Depressive Disorder
Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients
The purpose of this study is to evaluate the safety and efficacy of escitalopram to an active comparator in severely depressed patients
- Trial name
- NCT00384436
- Testing
- escitalopram
- Where
- United States
- Volunteers
- 580 people
- Sponsor
- Forest Laboratories
Major Depressive Disorder
Effects of Duloxetine vs. Escitalopram on Heart Rate Variability in Depression
Low heart rate variability is a marker of increased risk of cardiac mortality, and is observed in depressed coronary artery disease patients. Some antidepressants may themselves, however, decrease heart rate variability.
- Trial name
- NCT00215228
- Testing
- duloxetine vs. escitalopram
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- Duke University
Depression
Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram
This study is one component of a larger U01 grant that was submitted in August, 2004 to the NIGMS as part of the Pharmacogenomic Research Network. This study will enroll 1200 patients over 4 years.
- Trial name
- PGRN-SSRI (NCT00613470)
- Testing
- citalopram and escitalopram
- Where
- United States
- Volunteers
- 927 people
- Sponsor
- Mayo Clinic
Major Depressive Disorder
Investigation of a Combination Treatment of Escitalopram and rTMS
We intend to test in a randomized, rater blinded, placebo controlled, prospective study the primary hypothesis that an escitalopram-rTMS-combination treatment is more efficacious in the treatment of refractory major depression…
- Trial name
- NCT00232700
- Testing
- Escitalopram
- Where
- Germany
- Volunteers
- 42 people
- Sponsor
- Charite University, Berlin, Germany
Fibromyalgia
Comparative Efficacy of Duloxetine vs Escitalopram in Patients With Fibromyalgia
Duloxetine is FDA approved as pharmacological treatment for Fibromyalgia. The use of SSRIs has been endorsed by the 2013 Canadian guidelines.
- Trial name
- CORTEX (NCT03487211)
- Testing
- Duloxetine, Escitalopram
- Where
- Pakistan
- Volunteers
- 200 people
- Sponsor
- Shaheed Zulfiqar Ali Bhutto Medical University
Obsessive Compulsive Disorder
Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
The purpose of this study is to assess the efficacy of Escitalopram in the treatment of obsessive compulsive disorder and to determine the optimal treatment dose.
- Trial name
- NCT00116532
- Testing
- Escitalopram
- Where
- United States
- Volunteers
- 30 people
- Sponsor
- Massachusetts General Hospital